Skip to main content
Fig. 3 | BMC Ophthalmology

Fig. 3

From: Individualized treat-and-extend regime for optimization of real-world vision outcome and improved patients’ persistence

Fig. 3

TE injection scheme in RVO (baseline visual acuity 0.1): a) baseline and 1st injection. b) dry macula after first injection, extend possible but postponed in shared decision making with the patient. c) dry macula, now extension of intervals to enable a personalized regime. d) dry macula, further extension. e) dry macula, further extension. f) new fluid after extension to 10-week interval, 6th injection and fallback to last stable interval (8 weeks). g) dry macula after 8 weeks, new attempt for 10-week interval extension. h) dry macula 10 weeks after last injection, attempt to extend to 12 weeks. In total, eight injections were needed in the first year and a stable visual acuity gain to 0.5 was maintained

Back to article page